The
Animals
Anti-Arrhythmia Agents
/ pharmacology
Arrhythmias, Cardiac
/ drug therapy
Dose-Response Relationship, Drug
Fibroblasts
HEK293 Cells
Heart Rate
/ physiology
Humans
Ion Channel Gating
/ drug effects
KCNQ1 Potassium Channel
/ chemistry
Mefenamic Acid
/ pharmacology
Membrane Potentials
/ drug effects
Mice
Mutagenesis, Site-Directed
Mutation
Myocardium
/ metabolism
Patch-Clamp Techniques
Potassium
/ metabolism
Potassium Channels, Voltage-Gated
/ agonists
Recombinant Proteins
/ chemistry
Signal Transduction
/ drug effects
Journal
Molecular pharmacology
ISSN: 1521-0111
Titre abrégé: Mol Pharmacol
Pays: United States
ID NLM: 0035623
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
19
07
2019
accepted:
04
11
2019
pubmed:
15
11
2019
medline:
19
5
2020
entrez:
15
11
2019
Statut:
ppublish
Résumé
The pairing of KCNQ1 and KCNE1 subunits together mediates the cardiac slow delayed rectifier current (
Identifiants
pubmed: 31722973
pii: mol.119.117952
doi: 10.1124/mol.119.117952
doi:
Substances chimiques
Anti-Arrhythmia Agents
0
KCNE1 protein, human
0
KCNQ1 Potassium Channel
0
KCNQ1 protein, human
0
Potassium Channels, Voltage-Gated
0
Recombinant Proteins
0
Mefenamic Acid
367589PJ2C
Potassium
RWP5GA015D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
132-144Subventions
Organisme : CIHR
ID : PJT-156181
Pays : Canada
Informations de copyright
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.